BioLife Solutions, Inc. (BLFS) Financials
BLFS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 447.5 million | 27.5 million |
| March 31, 2026 | 400.9 million | 28.7 million |
| Dec. 31, 2025 | 405.9 million | 34.0 million |
| Sept. 30, 2025 | 392.1 million | 38.3 million |
BLFS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 6.5 million | -4.8 million |
| March 31, 2026 | -658000 | 4.8 million |
| Dec. 31, 2025 | -9.6 million | 7.1 million |
| Sept. 30, 2025 | 2.8 million | 5.9 million |
BLFS Net Income
No data available :(
BLFS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 82.4 million | - | 15.7 million |
| March 31, 2026 | 81.0 million | - | 12.4 million |
| Dec. 31, 2025 | 88.9 million | - | 12.9 million |
| Sept. 30, 2025 | 79.0 million | - | 13.2 million |
BLFS Shares Outstanding
BLFS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 167000 | 3.0 million | 13.5 million | 2.8 million |
| March 31, 2026 | 167000 | 2.7 million | 14.7 million | 2.5 million |
| Dec. 31, 2025 | 14.5 million | 66000 | 12.5 million | 2.0 million |
| Sept. 30, 2025 | 3.3 million | 2.7 million | 14.6 million | 2.5 million |
BLFS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 28.5 million | 10.2 million |
| March 31, 2026 | 27.5 million | 10.1 million |
| Dec. 31, 2025 | 18.8 million | 6.1 million |
| Sept. 30, 2025 | 28.1 million | 10.8 million |
BLFS Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BLFS
Price: $38.61
52 week price:
Payout Ratio Range:
Earnings Per Share: 1.00 USD
P/E Ratio: 34.82
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 447300
Ebitda: -233997Market Capitalization: 1.8 billion